{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:43:07Z","timestamp":1792640587690,"version":"4.5.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10390-7","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:31:20Z","timestamp":1792639880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Before the seeds arrive: pre-metastatic niche orchestration in bladder cancer"],"prefix":"10.1007","volume":"45","author":[{"given":"Da-Ming","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"6","key":"10390_CR1","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3322\/caac.70019","volume":"75","author":"W Yip","year":"2025","unstructured":"Yip, W., Jaime-Casas, S., Kothari, A., et al. (2025). Urothelial carcinoma: Perioperative considerations from top to bottom. CA: A Cancer Journal for Clinicians, 75(6), 528\u2013551. https:\/\/doi.org\/10.3322\/caac.70019","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"5","key":"10390_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","volume":"87","author":"AG van der Heijden","year":"2025","unstructured":"van der Heijden, A. G., Bruins, H. M., Carrion, A., et al. (2025). European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2025 guidelines. European Urology, 87(5), 582\u2013600. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.019","journal-title":"European Urology"},{"issue":"6","key":"10390_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41585-024-00963-y","volume":"22","author":"M Leyderman","year":"2025","unstructured":"Leyderman, M., Chandrasekar, T., Grivas, P., et al. (2025). Metastasis development in non-muscle-invasive bladder cancer. Nature Reviews. Urology, 22(6), 375\u2013386. https:\/\/doi.org\/10.1038\/s41585-024-00963-y","journal-title":"Nature Reviews. Urology"},{"issue":"12","key":"10390_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41585-025-01072-0","volume":"22","author":"L Wen","year":"2025","unstructured":"Wen, L., Miyagi, H., Spiess, P. E., et al. (2025). Low-grade non-muscle-invasive bladder cancer: Molecular landscape, treatment strategies and emerging therapies. Nature Reviews. Urology, 22(12), 846\u2013861. https:\/\/doi.org\/10.1038\/s41585-025-01072-0","journal-title":"Nature Reviews. Urology"},{"issue":"27","key":"10390_CR5","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1200\/JCO-25-00718","volume":"43","author":"MD Galsky","year":"2025","unstructured":"Galsky, M. D., Ballas, L., & Kamat, A. M. (2025). Muscle-invasive bladder cancer: A watershed moment. Journal of Clinical Oncology, 43(27), 3041\u20133051. https:\/\/doi.org\/10.1200\/JCO-25-00718","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10390_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.eururo.2026.01.029","volume":"89","author":"S Gupta","year":"2026","unstructured":"Gupta, S., Li, R., Hensley, P. J., et al. (2026). Optimal management of muscle-invasive bladder cancer: Recommendations from the international bladder cancer group. European Urology, 89(6), 500\u2013511. https:\/\/doi.org\/10.1016\/j.eururo.2026.01.029","journal-title":"European Urology"},{"issue":"3","key":"10390_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E., & Joyce, J. A. (2023). The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell, 41(3), 374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016","journal-title":"Cancer Cell"},{"issue":"8","key":"10390_CR8","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger, S., Jiang, Q., & Ganesh, K. (2023). Metastasis. Cell., 186(8), 1564\u20131579. https:\/\/doi.org\/10.1016\/j.cell.2023.03.003","journal-title":"Metastasis. Cell."},{"issue":"1","key":"10390_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li, Y., Liu, F., Cai, Q., et al. (2025). Invasion and metastasis in cancer: Molecular insights and therapeutic targets. Signal Transduction and Targeted Therapy, 10(1), 57. https:\/\/doi.org\/10.1038\/s41392-025-02148-4","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10390_CR10","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","volume":"189","author":"D Hanahan","year":"2026","unstructured":"Hanahan, D. (2026). Hallmarks of cancer-then and now, and beyond. Cell, 189(8), 2254\u20132277. https:\/\/doi.org\/10.1016\/j.cell.2025.12.049","journal-title":"Cell"},{"issue":"1","key":"10390_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-026-02645-2","volume":"25","author":"XR Zhang","year":"2026","unstructured":"Zhang, X. R., Wei, B., Jiang, B. H., et al. (2026). The pre-metastatic niche: Mechanisms, heterogeneity, and therapeutic opportunities. Molecular Cancer, 25(1), 117. https:\/\/doi.org\/10.1186\/s12943-026-02645-2","journal-title":"Molecular Cancer"},{"issue":"1","key":"10390_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12964-026-02727-0","volume":"24","author":"H Huang","year":"2026","unstructured":"Huang, H., Lu, X., Liu, Y., et al. (2026). The unseen architects of metastasis: Coagulation factors in pre-metastatic niche development. Cell Communication and Signaling: CCS, 24(1), 178. https:\/\/doi.org\/10.1186\/s12964-026-02727-0","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10390_CR13","doi-asserted-by":"publisher","first-page":"218102","DOI":"10.1016\/j.canlet.2025.218102","volume":"635","author":"Z Guo","year":"2025","unstructured":"Guo, Z., Liu, J., Zhang, M., et al. (2025). Biomechanical networks of the pre-metastatic niche: Decoding biophysical determinants of tumor metastatic organotropism. Cancer Letters, 635, 218102. https:\/\/doi.org\/10.1016\/j.canlet.2025.218102","journal-title":"Cancer Letters"},{"issue":"8","key":"10390_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/cac2.70034","volume":"45","author":"S Li","year":"2025","unstructured":"Li, S., Zhou, J., Wang, S., et al. (2025). N6-methyladenosine-regulated exosome biogenesis orchestrates an immunosuppressive pre-metastatic niche in gastric cancer peritoneal metastasis. Cancers Communication (London, England), 45(8), 941\u2013965. https:\/\/doi.org\/10.1002\/cac2.70034","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"10390_CR15","doi-asserted-by":"publisher","first-page":"189360","DOI":"10.1016\/j.bbcan.2025.189360","volume":"1880","author":"X Chang","year":"2025","unstructured":"Chang, X., Yao, Y., Zhang, M., et al. (2025). Spatiotemporal dynamics of the pre-metastatic niche: Remodeling of lung microenvironment before breast cancer metastasis and targeted intervention strategies. Biochimica et Biophysica Acta - Reviews on Cancer, 1880(4), 189360. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189360","journal-title":"Biochimica et Biophysica Acta - Reviews on Cancer"},{"issue":"1","key":"10390_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02315-9","volume":"24","author":"X Zhou","year":"2025","unstructured":"Zhou, X., Li, R., Lai, M., et al. (2025). Exploring molecular and cellular mechanisms of pre-metastatic niche in renal cell carcinoma. Molecular Cancer, 24(1), Article 121. https:\/\/doi.org\/10.1186\/s12943-025-02315-9","journal-title":"Molecular Cancer"},{"issue":"12","key":"10390_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41568-024-00752-0","volume":"24","author":"N Rabas","year":"2024","unstructured":"Rabas, N., Ferreira, R. M. M., Di Blasio, S., et al. (2024). Cancer-induced systemic pre-conditioning of distant organs: Building a niche for metastatic cells. Nature Reviews Cancer, 24(12), 829\u2013849. https:\/\/doi.org\/10.1038\/s41568-024-00752-0","journal-title":"Nature Reviews Cancer"},{"issue":"8113","key":"10390_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41586-026-10157-8","volume":"653","author":"G Skrupskelyte","year":"2026","unstructured":"Skrupskelyte, G., Rojo Arias, J. E., Ajith, H., et al. (2026). Precancerous niche remodelling dictates nascent tumour persistence. Nature, 653(8113), 242\u2013253. https:\/\/doi.org\/10.1038\/s41586-026-10157-8","journal-title":"Nature"},{"issue":"7","key":"10390_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41568-025-00814-x","volume":"25","author":"K Naxerova","year":"2025","unstructured":"Naxerova, K. (2025). Evolutionary paths towards metastasis. Nature Reviews Cancer, 25(7), 545\u2013560. https:\/\/doi.org\/10.1038\/s41568-025-00814-x","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10390_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40164-025-00733-5","volume":"15","author":"Q Lan","year":"2026","unstructured":"Lan, Q., Xu, H., Zeng, Y., et al. (2026). PRL-3 up-regulates exosomal ITG\u03b1v\u03b25 expression to promote liver pre-metastatic niche formation and colon cancer liver metastasis. Experimental Hematology & Oncology, 15(1), 6. https:\/\/doi.org\/10.1186\/s40164-025-00733-5","journal-title":"Experimental Hematology & Oncology"},{"issue":"1","key":"10390_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41419-026-08515-5","volume":"17","author":"B Lin","year":"2026","unstructured":"Lin, B., Luo, M., Zhou, Y., et al. (2026). CRMP2 inhibits metastasis formation by impairing ILF3-dependent stabilization of CXCL10 mRNA in breast cancer. Cell Death & Disease, 17(1), 255. https:\/\/doi.org\/10.1038\/s41419-026-08515-5","journal-title":"Cell Death & Disease"},{"issue":"8049","key":"10390_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-024-08335-7","volume":"638","author":"G Doglioni","year":"2025","unstructured":"Doglioni, G., Fern\u00e1ndez-Garc\u00eda, J., Igelmann, S., et al. (2025). Aspartate signalling drives lung metastasis via alternative translation. Nature, 638(8049), 244\u2013250. https:\/\/doi.org\/10.1038\/s41586-024-08335-7","journal-title":"Nature"},{"issue":"1","key":"10390_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12964-026-02738-x","volume":"24","author":"M Loria","year":"2026","unstructured":"Loria, M., Anello, D., Cordaro, A., et al. (2026). Long non-coding RNA H19 transported by colorectal cancer small extracellular vesicles promotes alternative splicing in healthy hepatocytes: New insights on liver pre-metastatic niche formation. Cell Communication and Signaling: CCS, 24(1), 194. https:\/\/doi.org\/10.1186\/s12964-026-02738-x","journal-title":"Cell Communication and Signaling: CCS"},{"issue":"11","key":"10390_CR24","doi-asserted-by":"publisher","first-page":"e70094","DOI":"10.1002\/jex2.70094","volume":"4","author":"M Shelton","year":"2025","unstructured":"Shelton, M., Anene, C. A., Nsengimana, J., et al. (2025). Extracellular vesicles from a model of melanoma cancer-associated fibroblasts induce changes in brain microvascular cells consistent with pre-metastatic niche priming. Journal of Extracellular Biology, 4(11), e70094. https:\/\/doi.org\/10.1002\/jex2.70094","journal-title":"J Extracell Biol"},{"issue":"1","key":"10390_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-025-02385-0","volume":"11","author":"F Wang","year":"2025","unstructured":"Wang, F., Li, L., Sun, X., et al. (2025). The feedback loop between miR-222-3p and ZEB1 harnesses metastasis in renal cell carcinoma. Cell Death Discovery, 11(1), 97. https:\/\/doi.org\/10.1038\/s41420-025-02385-0","journal-title":"Cell Death Discov"},{"issue":"10","key":"10390_CR26","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.7150\/ijbs.110750","volume":"21","author":"S Xu","year":"2025","unstructured":"Xu, S., Peng, X., Wang, Z., et al. (2025). FABP7-mediated lipid-laden macrophages drive the formation of pre-metastatic niche and liver metastasis. International Journal of Biological Sciences, 21(10), 4388\u20134409. https:\/\/doi.org\/10.7150\/ijbs.110750","journal-title":"International Journal of Biological Sciences"},{"issue":"3","key":"10390_CR27","doi-asserted-by":"publisher","first-page":"117101","DOI":"10.1016\/j.celrep.2026.117101","volume":"45","author":"F Fercoq","year":"2026","unstructured":"Fercoq, F., Cairns, G. S., Bridgeman, V. L., et al. (2026). Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer. Cell Reports, 45(3), 117101. https:\/\/doi.org\/10.1016\/j.celrep.2026.117101","journal-title":"Cell Reports"},{"issue":"1","key":"10390_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","volume":"43","author":"W Lee","year":"2025","unstructured":"Lee, W., Ko, S. Y., Akasaka, H., et al. (2025). Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10. Cancer Cell, 43(1), 69-85.e11. https:\/\/doi.org\/10.1016\/j.ccell.2024.12.004","journal-title":"Cancer Cell"},{"issue":"1","key":"10390_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02379-6","volume":"23","author":"Z Zhao","year":"2025","unstructured":"Zhao, Z., Xiong, S., Guo, E., et al. (2025). PDPN+LTBP1+ cancer-associated fibroblasts induce a liver pre-metastatic niche in gastric cancer via PDPN\/YAP\/LTBP1 and CCL11\/CCR3 axis. Cell Communication and Signaling, 23(1), Article 402. https:\/\/doi.org\/10.1186\/s12964-025-02379-6","journal-title":"Cell Communication and Signaling"},{"issue":"3","key":"10390_CR30","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.7150\/ijbs.87680","volume":"20","author":"H Han","year":"2024","unstructured":"Han, H., Qian, C., Song, M., et al. (2024). Fibroblasts: Invigorated targets in pre-metastatic niche formation. International Journal of Biological Sciences, 20(3), 1110\u20131124. https:\/\/doi.org\/10.7150\/ijbs.87680","journal-title":"International Journal of Biological Sciences"},{"issue":"4","key":"10390_CR31","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10456-024-09947-3","volume":"27","author":"H Feng","year":"2024","unstructured":"Feng, H., Liang, L., Deng, W., et al. (2024). Sialyl Lewis X decorated integrin \u03b13 on small extracellular vesicles promotes metastasis of bladder cancer via enhancing vascular permeability. Angiogenesis, 27(4), 883\u2013901. https:\/\/doi.org\/10.1007\/s10456-024-09947-3","journal-title":"Angiogenesis"},{"issue":"23","key":"10390_CR32","doi-asserted-by":"publisher","first-page":"e23256","DOI":"10.1002\/advs.202523256","volume":"13","author":"W Shangguan","year":"2026","unstructured":"Shangguan, W., Li, W., Huang, W., et al. (2026). FomA-containing outer membrane vesicles of Fusobacterium nucleatum facilitate bladder cancer lymphatic metastasis via IL-6-dependent M2b macrophage polarization. Advance Science (Weinheim, Baden-Wurttemberg, Germany)., 13(23), e23256. https:\/\/doi.org\/10.1002\/advs.202523256","journal-title":"Adv Sci (Weinh)."},{"issue":"7","key":"10390_CR33","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/cas.14080","volume":"110","author":"K Yoshida","year":"2019","unstructured":"Yoshida, K., Tsuda, M., Matsumoto, R., et al. (2019). Exosomes containing ErbB2\/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer. Cancer Science, 110(7), 2119\u20132132. https:\/\/doi.org\/10.1111\/cas.14080","journal-title":"Cancer Science"},{"issue":"3","key":"10390_CR34","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.ymthe.2026.01.035","volume":"34","author":"Z Chen","year":"2026","unstructured":"Chen, Z., Chen, X., Xie, R., et al. (2026). DANCR promotes metastasis and proliferation in bladder cancer cells by enhancing IL-11-STAT3 signaling and CCND1 expression. Molecular Therapy, 34(3), 1867. https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.035","journal-title":"Molecular Therapy"},{"issue":"4","key":"10390_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2025.102378","volume":"23","author":"SU Engelmann","year":"2025","unstructured":"Engelmann, S. U., Pickl, C., Haas, M., et al. (2025). Prognostic role of serum IL-6 levels in bladder cancer patients and hints of its origin. Clinical Genitourinary Cancer, 23(4), Article 102378. https:\/\/doi.org\/10.1016\/j.clgc.2025.102378","journal-title":"Clinical Genitourinary Cancer"},{"issue":"7","key":"10390_CR36","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1002\/ctm2.497","volume":"11","author":"H Zheng","year":"2021","unstructured":"Zheng, H., Chen, C., Luo, Y., et al. (2021). Tumor-derived exosomal BCYRN1 activates WNT5A\/VEGF-C\/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer. Clinical and Translational Medicine, 11(7), e497. https:\/\/doi.org\/10.1002\/ctm2.497","journal-title":"Clinical and Translational Medicine"},{"issue":"Pt 4","key":"10390_CR37","doi-asserted-by":"publisher","first-page":"122589","DOI":"10.1016\/j.envres.2025.122589","volume":"285","author":"B Yi","year":"2025","unstructured":"Yi, B., Zhao, Z., Gao, X., et al. (2025). Antimony exposure induces bladder cancer metastasis via activation of the SUMOylation-dependent TGF-\u03b2\/Smad2\/3 axis. Environmental Research, 285(Pt 4), 122589. https:\/\/doi.org\/10.1016\/j.envres.2025.122589","journal-title":"Environmental Research"},{"key":"10390_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ebiom.2019.08.012","volume":"47","author":"Z Chen","year":"2019","unstructured":"Chen, Z., He, S., Zhan, Y., et al. (2019). TGF-\u03b2-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation. eBioMedicine, 47, 208\u2013220. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.012","journal-title":"eBioMedicine"},{"issue":"6","key":"10390_CR39","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/2159-8290.CD-25-1774","volume":"16","author":"MA Tran","year":"2026","unstructured":"Tran, M. A., Cho, B. A., Izadmehr, S., et al. (2026). A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancer. Cancer Discovery, 16(6), 1126\u20131151. https:\/\/doi.org\/10.1158\/2159-8290.CD-25-1774","journal-title":"Cancer Discovery"},{"issue":"1","key":"10390_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-025-01749-4","volume":"18","author":"JM Wang","year":"2025","unstructured":"Wang, J. M., Xie, H. Y., Zhang, F. H., et al. (2025). Aberrant KIF26B expression promotes bladder cancer progression through driving NSUN2 nuclear localization. Journal of Hematology & Oncology, 18(1), 110. https:\/\/doi.org\/10.1186\/s13045-025-01749-4","journal-title":"Journal of Hematology & Oncology"},{"issue":"5","key":"10390_CR41","doi-asserted-by":"publisher","first-page":"167811","DOI":"10.1016\/j.bbadis.2025.167811","volume":"1871","author":"L Chen","year":"2025","unstructured":"Chen, L., He, C., Ou, Z., et al. (2025). TNF-\u03b1 drives bladder cancer metastasis via METTL3-mediated m6A modification to promote CLASP2\/IQGAP1-dependent cytoskeleton remodeling. Biochimica et Biophysica Acta, Molecular Basis of Disease, 1871(5), 167811. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167811","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"key":"10390_CR42","doi-asserted-by":"publisher","first-page":"101103","DOI":"10.1016\/j.neo.2024.101103","volume":"60","author":"R Nakagawa","year":"2025","unstructured":"Nakagawa, R., Izumi, K., Hiratsuka, K., et al. (2025). Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis. Neoplasia, 60, 101103. https:\/\/doi.org\/10.1016\/j.neo.2024.101103","journal-title":"Neoplasia"},{"issue":"2","key":"10390_CR43","doi-asserted-by":"publisher","first-page":"e171164","DOI":"10.1172\/JCI171164","volume":"135","author":"P Sadhukhan","year":"2024","unstructured":"Sadhukhan, P., Feng, M., Illingworth, E., et al. (2024). YAP1 induces bladder cancer progression and promotes immune evasion through IL-6\/STAT3 pathway and CXCL deregulation. The Journal of Clinical Investigation, 135(2), e171164. https:\/\/doi.org\/10.1172\/JCI171164","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10390_CR44","doi-asserted-by":"publisher","first-page":"686","DOI":"10.21147\/j.issn.1000-9604.2023.06.12","volume":"35","author":"Z Tuo","year":"2023","unstructured":"Tuo, Z., Feng, D., Jiang, Z., et al. (2023). Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis. Chinese Journal of Cancer Research, 35(6), 686\u2013701. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2023.06.12","journal-title":"Chinese Journal of Cancer Research"},{"key":"10390_CR45","doi-asserted-by":"publisher","first-page":"175883592513492","DOI":"10.1177\/17588359251349288","volume":"17","author":"J Chen","year":"2025","unstructured":"Chen, J., Yang, X., Hao, Z., et al. (2025). Extracellular vesicles-derived extracellular RNA in bladder cancer: Current progress and future prospects. Therapeutic Advances in Medical Oncology, 17, 17588359251349288. https:\/\/doi.org\/10.1177\/17588359251349288","journal-title":"Ther Adv Med Oncol"},{"issue":"26","key":"10390_CR46","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1038\/s41388-025-03380-6","volume":"44","author":"CH Wu","year":"2025","unstructured":"Wu, C. H., Yuen, K. L., Molony, R. D., et al. (2025). Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder. Oncogene, 44(26), 2158\u20132169. https:\/\/doi.org\/10.1038\/s41388-025-03380-6","journal-title":"Oncogene"},{"issue":"11","key":"10390_CR47","doi-asserted-by":"publisher","first-page":"e70179","DOI":"10.1002\/jev2.70179","volume":"14","author":"CS Huang","year":"2025","unstructured":"Huang, C. S., Yu, D. S., Jiang, S. S., et al. (2025). Extracellular vesicle-mediated regulation of H3C14 contributes to gemcitabine resistance in bladder cancer. Journal of Extracellular Vesicles (JEV), 14(11), e70179. https:\/\/doi.org\/10.1002\/jev2.70179","journal-title":"J Extracell Vesicles."},{"issue":"3","key":"10390_CR48","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ymthe.2022.01.022","volume":"30","author":"C Yang","year":"2022","unstructured":"Yang, C., Wu, S., Mou, Z., et al. (2022). Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments. Molecular Therapy, 30(3), 1054\u20131070. https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.022","journal-title":"Molecular Therapy"},{"issue":"1","key":"10390_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41420-026-02992-5","volume":"12","author":"X Bao","year":"2026","unstructured":"Bao, X., Hou, B., Guo, Z., et al. (2026). Absolute dynamic and relative static: The relationship of glycolysis and OXPHOS in cancer development. Cell Death Discovery, 12(1), 136. https:\/\/doi.org\/10.1038\/s41420-026-02992-5","journal-title":"Cell Death Discov"},{"issue":"3","key":"10390_CR50","doi-asserted-by":"publisher","first-page":"101772","DOI":"10.1016\/j.gendis.2025.101772","volume":"13","author":"W Zhang","year":"2025","unstructured":"Zhang, W., Wang, P., Yuan, G., et al. (2025). Fatty acid metabolic reprogramming in the tumor microenvironment: Unraveling mechanisms and therapeutic prospects. Genes & Diseases, 13(3), 101772. https:\/\/doi.org\/10.1016\/j.gendis.2025.101772","journal-title":"Genes Dis."},{"issue":"50","key":"10390_CR51","doi-asserted-by":"publisher","first-page":"41985","DOI":"10.1021\/acsnano.4c15108","volume":"19","author":"R Zheng","year":"2025","unstructured":"Zheng, R., Xiao, Y., Yang, J., et al. (2025). Extracellular vesicle-packaged MIR4435-2HG facilitates cigarette smoke-induced bladder cancer progression through enolase 1-dependent glycolytic reprogramming. ACS Nano, 19(50), 41985\u201342001. https:\/\/doi.org\/10.1021\/acsnano.4c15108","journal-title":"ACS Nano"},{"key":"10390_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2021.09.036","volume":"523","author":"X Li","year":"2021","unstructured":"Li, X., Wei, Z., Yu, H., et al. (2021). Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis. Cancer Letters, 523, 10\u201328. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.036","journal-title":"Cancer Letters"},{"issue":"19","key":"10390_CR53","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1158\/0008-5472.CAN-24-3439","volume":"85","author":"C Chen","year":"2025","unstructured":"Chen, C., Gao, Y., Lu, R., et al. (2025). TERC stimulates fatty acid metabolism to promote bladder cancer progression. Cancer Research, 85(19), 3689\u20133705. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3439","journal-title":"Cancer Research"},{"issue":"1","key":"10390_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-024-01968-2","volume":"23","author":"X Shi","year":"2024","unstructured":"Shi, X., Pang, S., Zhou, J., et al. (2024). Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs. Molecular Cancer, 23(1), 52. https:\/\/doi.org\/10.1186\/s12943-024-01968-2","journal-title":"Molecular Cancer"},{"issue":"7","key":"10390_CR55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrurol.2013.113","volume":"10","author":"H Yoshino","year":"2013","unstructured":"Yoshino, H., Seki, N., Itesako, T., et al. (2013). Aberrant expression of microRNAs in bladder cancer. Nature Reviews Urology, 10(7), 396\u2013404. https:\/\/doi.org\/10.1038\/nrurol.2013.113","journal-title":"Nature Reviews Urology"},{"key":"10390_CR56","doi-asserted-by":"publisher","first-page":"217352","DOI":"10.1016\/j.canlet.2024.217352","volume":"609","author":"L Steiner","year":"2025","unstructured":"Steiner, L., Eldh, M., Offens, A., et al. (2025). Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer. Cancer Letters, 609, 217352. https:\/\/doi.org\/10.1016\/j.canlet.2024.217352","journal-title":"Cancer Letters"},{"issue":"7069","key":"10390_CR57","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N., Riba, R. D., Zacharoulis, S., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820\u2013827. https:\/\/doi.org\/10.1038\/nature04186","journal-title":"Nature"},{"issue":"8","key":"10390_CR58","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/diagnostics13081471","volume":"13","author":"M El Azzouzi","year":"2023","unstructured":"El Azzouzi, M., El Ahanidi, H., Hafidi Alaoui, C., et al. (2023). The evaluation of vascular endothelial growth factor A (VEGFA) and VEGFR2 receptor as prognostic biomarkers in bladder cancer. Diagnostics (Basel), 13(8), 1471. https:\/\/doi.org\/10.3390\/diagnostics13081471","journal-title":"Diagnostics (Basel)"},{"key":"10390_CR59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fimmu.2019.00172","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Ding, Y., Guo, N., et al. (2019). MDSCs: Key criminals of tumor pre-metastatic niche formation. Frontiers in Immunology, 10, 172. https:\/\/doi.org\/10.3389\/fimmu.2019.00172","journal-title":"Frontiers in Immunology"},{"key":"10390_CR60","doi-asserted-by":"publisher","first-page":"149772","DOI":"10.1016\/j.gene.2025.149772","volume":"970","author":"S Boillat","year":"2025","unstructured":"Boillat, S., Goasmat, V., Derr\u00e9, L., et al. (2025). Role of myeloid-derived suppressor cells in bladder cancer and targeted therapeutic strategies. Gene, 970, 149772. https:\/\/doi.org\/10.1016\/j.gene.2025.149772","journal-title":"Gene"},{"issue":"4","key":"10390_CR61","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1158\/2326-6066.CIR-19-0507","volume":"8","author":"H Xiang","year":"2020","unstructured":"Xiang, H., Ramil, C. P., Hai, J., et al. (2020). Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunology Research, 8(4), 436\u2013450. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0507","journal-title":"Cancer Immunology Research"},{"issue":"3","key":"10390_CR62","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.ncrna.2024.03.003","volume":"9","author":"L Feng","year":"2024","unstructured":"Feng, L., Li, M., Ma, J., et al. (2024). ALKBH5 regulates arginase 1 expression in MDSCs and their immunosuppressive activity in tumor-bearing host. Non-coding RNA Research, 9(3), 913\u2013920. https:\/\/doi.org\/10.1016\/j.ncrna.2024.03.003","journal-title":"Noncoding RNA Res"},{"issue":"17","key":"10390_CR63","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/cancers16173055","volume":"16","author":"GP Takacs","year":"2024","unstructured":"Takacs, G. P., Garcia, J. S., Hodges, C. A., et al. (2024). CSF1R ligands expressed by murine gliomas promote M-MDSCs to suppress CD8+ T cells in a NOS-dependent manner. Cancers (Basel), 16(17), 3055. https:\/\/doi.org\/10.3390\/cancers16173055","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10390_CR64","doi-asserted-by":"publisher","first-page":"e2409537","DOI":"10.1002\/advs.202409537","volume":"12","author":"X Wu","year":"2025","unstructured":"Wu, X., Pan, B., Chu, C., et al. (2025). CXCL16\/CXCR6\/TGF-\u03b2 feedback loop between M-MDSCs and Treg inhibits anti-bacterial immunity during biofilm infection. Advance Science (Weinheim, Baden-Wurttemberg, Germany), 12(7), e2409537. https:\/\/doi.org\/10.1002\/advs.202409537","journal-title":"Adv Sci (Weinh)"},{"key":"10390_CR65","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.freeradbiomed.2025.11.001","volume":"242","author":"Y Wang","year":"2026","unstructured":"Wang, Y., Zhang, X., Yang, W., et al. (2026). Caveolin-1 drives ferroptosis in MDSCs via PKA-DRP1-mediated ER-mitochondria crosstalk to shape breast cancer immunosuppression. Free Radical Biology & Medicine, 242, 601\u2013613. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.11.001","journal-title":"Free Radical Biology & Medicine"},{"issue":"11","key":"10390_CR66","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181243","volume":"135","author":"Q Liao","year":"2025","unstructured":"Liao, Q., Zhou, X., Wu, L., et al. (2025). Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs. Journal of Clinical Investigation, 135(11), Article e181243. https:\/\/doi.org\/10.1172\/JCI181243","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10390_CR67","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003416","volume":"10","author":"Y Xu","year":"2022","unstructured":"Xu, Y., Zeng, H., Jin, K., et al. (2022). Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. Journal for Immunotherapy of Cancer, 10(3), Article e003416. https:\/\/doi.org\/10.1136\/jitc-2021-003416","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"7","key":"10390_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011319","volume":"13","author":"H Chen","year":"2025","unstructured":"Chen, H., Jin, Z., Peng, Y., et al. (2025). Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer. Journal for Immunotherapy of Cancer, 13(7), Article e011319. https:\/\/doi.org\/10.1136\/jitc-2024-011319","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"1","key":"10390_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46735-5","volume":"15","author":"M Cheng","year":"2024","unstructured":"Cheng, M., Chen, S., Li, K., et al. (2024). CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer. Nature Communications, 15(1), Article 2818. https:\/\/doi.org\/10.1038\/s41467-024-46735-5","journal-title":"Nature Communications"},{"issue":"12","key":"10390_CR70","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma, Z., Li, X., Mao, Y., et al. (2022). Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell, 40(12), 1550-1565.e7. https:\/\/doi.org\/10.1016\/j.ccell.2022.11.005","journal-title":"Cancer Cell"},{"issue":"4","key":"10390_CR71","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ccell.2024.02.002","volume":"42","author":"H Zheng","year":"2024","unstructured":"Zheng, H., An, M., Luo, Y., et al. (2024). PDGFR\u03b1+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay. Cancer Cell, 42(4), 682-700.e12. https:\/\/doi.org\/10.1016\/j.ccell.2024.02.002","journal-title":"Cancer Cell"},{"issue":"11","key":"10390_CR72","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s43587-024-00704-1","volume":"4","author":"S Meguro","year":"2024","unstructured":"Meguro, S., Johmura, Y., Wang, T. W., et al. (2024). Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion. Nature Aging, 4(11), 1582\u20131597. https:\/\/doi.org\/10.1038\/s43587-024-00704-1","journal-title":"Nature Aging"},{"issue":"5","key":"10390_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41577-025-01248-0","volume":"26","author":"L Sorokin","year":"2026","unstructured":"Sorokin, L. (2026). Biochemical signals from the extracellular matrix in inflammation and tumour immunology. Nature Reviews Immunology, 26(5), 350\u2013366. https:\/\/doi.org\/10.1038\/s41577-025-01248-0","journal-title":"Nature Reviews Immunology"},{"issue":"15","key":"10390_CR74","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.7150\/ijbs.119301","volume":"21","author":"DL Boaru","year":"2025","unstructured":"Boaru, D. L., De Leon-Oliva, D., De Castro-Martinez, P., et al. (2025). Extracellular matrix dysregulation in aging, calcification, and cancer diseases: Insights into cellular senescence, inflammation, and novel therapeutic strategies. International Journal of Biological Sciences, 21(15), 6808\u20136881. https:\/\/doi.org\/10.7150\/ijbs.119301","journal-title":"International Journal of Biological Sciences"},{"key":"10390_CR75","doi-asserted-by":"publisher","first-page":"0215","DOI":"10.34133\/research.0215","volume":"6","author":"J Lv","year":"2023","unstructured":"Lv, J., Liu, X., Zhou, Y., et al. (2023). YAP inactivation by soft mechanotransduction relieves MAFG for tumor cell dedifferentiation. Research (Washington, D.C.), 6, 0215. https:\/\/doi.org\/10.34133\/research.0215","journal-title":"Research (Wash D C)"},{"issue":"4","key":"10390_CR76","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s42254-024-00707-2","volume":"6","author":"A Massey","year":"2024","unstructured":"Massey, A., Stewart, J., Smith, C., et al. (2024). Mechanical properties of human tumour tissues and their implications for cancer development. Nature Reviews Physics, 6(4), 269\u2013282. https:\/\/doi.org\/10.1038\/s42254-024-00707-2","journal-title":"Nat Rev Phys"},{"issue":"2","key":"10390_CR77","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","volume":"21","author":"SA Lasser","year":"2024","unstructured":"Lasser, S. A., Ozbay Kurt, F. G., Arkhypov, I., et al. (2024). Myeloid-derived suppressor cells in cancer and cancer therapy. Nature Reviews Clinical Oncology, 21(2), 147\u2013164. https:\/\/doi.org\/10.1038\/s41571-023-00846-y","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"21","key":"10390_CR78","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/cells13211779","volume":"13","author":"C Klein","year":"2024","unstructured":"Klein, C., Mebroukine, S., Mad\u00e9ry, M., et al. (2024). Myeloid-derived suppressor cells in bladder cancer: An emerging target. Cells, 13(21), 1779. https:\/\/doi.org\/10.3390\/cells13211779","journal-title":"Cells"},{"issue":"30","key":"10390_CR79","doi-asserted-by":"publisher","first-page":"e2202993","DOI":"10.1002\/advs.202202993","volume":"9","author":"X Li","year":"2022","unstructured":"Li, X., Peng, X., Zhang, C., et al. (2022). Bladder cancer-derived small extracellular vesicles promote tumor angiogenesis by inducing HBP-related metabolic reprogramming and SerRS O-GlcNAcylation in endothelial cells. Advance Science (Weinheim, Baden-Wurttemberg, Germany), 9(30), e2202993. https:\/\/doi.org\/10.1002\/advs.202202993","journal-title":"Adv Sci (Weinh)."},{"issue":"9","key":"10390_CR80","doi-asserted-by":"publisher","first-page":"nwae231","DOI":"10.1093\/nsr\/nwae231","volume":"11","author":"J Li","year":"2024","unstructured":"Li, J., Wang, D., Tang, F., et al. (2024). Pan-cancer integrative analyses dissect the remodeling of endothelial cells in human cancers. National Science Review, 11(9), nwae231. https:\/\/doi.org\/10.1093\/nsr\/nwae231","journal-title":"National Science Review"},{"issue":"4","key":"10390_CR81","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/carcin\/bgad013","volume":"44","author":"K Liu","year":"2023","unstructured":"Liu, K., Dou, R., Yang, C., et al. (2023). Exosome-transmitted miR-29a induces colorectal cancer metastasis by destroying the vascular endothelial barrier. Carcinogenesis, 44(4), 356\u2013367. https:\/\/doi.org\/10.1093\/carcin\/bgad013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10390_CR82","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-017-0740-6","volume":"16","author":"N Dioufa","year":"2017","unstructured":"Dioufa, N., Clark, A. M., Ma, B., et al. (2017). Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells. Molecular Cancer, 16(1), 172. https:\/\/doi.org\/10.1186\/s12943-017-0740-6","journal-title":"Molecular Cancer"},{"issue":"1","key":"10390_CR83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41698-025-00859-z","volume":"9","author":"C Cao","year":"2025","unstructured":"Cao, C., Wang, Y., Deng, X., et al. (2025). Exosomes containing miR-152-3p targeting FGFR3 mediate SLC7A7-induced angiogenesis in bladder cancer. npj Precision Oncology, 9(1), 71. https:\/\/doi.org\/10.1038\/s41698-025-00859-z","journal-title":"NPJ Precis Oncol."},{"issue":"1","key":"10390_CR84","doi-asserted-by":"publisher","first-page":"2290033","DOI":"10.1080\/15384047.2023.2290033","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu, Z., Du, D., & Zhang, S. (2024). Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1. Cancer Biology & Therapy, 25(1), 2290033. https:\/\/doi.org\/10.1080\/15384047.2023.2290033","journal-title":"Cancer Biology & Therapy"},{"key":"10390_CR85","doi-asserted-by":"publisher","first-page":"6341256","DOI":"10.1155\/2020\/6341256","volume":"2020","author":"B Chen","year":"2020","unstructured":"Chen, B., Bu, R., & Xu, X. (2020). Expression of tight junction proteins is altered in bladder cancer. Analytical Cellular Pathology (Amsterdam), 2020, 6341256. https:\/\/doi.org\/10.1155\/2020\/6341256","journal-title":"Analytical Cellular Pathology (Amsterdam)"},{"issue":"12","key":"10390_CR86","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/biom15121696","volume":"15","author":"GC Okura","year":"2025","unstructured":"Okura, G. C., Bharadwaj, A. G., & Waisman, D. M. (2025). The role of extracellular proteases and extracellular matrix remodeling in the pre-metastatic niche. Biomolecules, 15(12), 1696. https:\/\/doi.org\/10.3390\/biom15121696","journal-title":"Biomolecules"},{"issue":"1","key":"10390_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-025-02328-2","volume":"11","author":"Y Liang","year":"2026","unstructured":"Liang, Y., Chen, W. M., Zhang, Y., et al. (2026). Remodeling the tumor dormancy ecosystem to prevent recurrence and metastasis. Signal Transduction and Targeted Therapy, 11(1), 1. https:\/\/doi.org\/10.1038\/s41392-025-02328-2","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8096","key":"10390_CR88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/d41586-025-04149-3","volume":"649","author":"A Heidt","year":"2026","unstructured":"Heidt, A. (2026). Why cancer can come back years later - and how to stop it. Nature, 649(8096), 282\u2013284. https:\/\/doi.org\/10.1038\/d41586-025-04149-3","journal-title":"Nature"},{"issue":"1","key":"10390_CR89","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s43018-025-01094-y","volume":"7","author":"Z Wang","year":"2026","unstructured":"Wang, Z., Elbanna, Y., Godet, I., et al. (2026). TGF\u03b2 induces an atypical EMT to evade immune mechanosurveillance in lung adenocarcinoma dormant metastasis. Nature Cancer, 7(1), 131\u2013149. https:\/\/doi.org\/10.1038\/s43018-025-01094-y","journal-title":"Nat Cancer."},{"issue":"6","key":"10390_CR90","doi-asserted-by":"publisher","first-page":"112560","DOI":"10.1016\/j.celrep.2023.112560","volume":"42","author":"DK Singh","year":"2023","unstructured":"Singh, D. K., Carcamo, S., Farias, E. F., et al. (2023). 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-\u03b2-SMAD4 signaling. Cell Reports, 42(6), 112560. https:\/\/doi.org\/10.1016\/j.celrep.2023.112560","journal-title":"Cell Reports"},{"issue":"1","key":"10390_CR91","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier, C., Baker, D., Ten Dijke, P., et al. (2019). TGF-\u03b2 family signaling pathways in cellular dormancy. Trends Cancer, 5(1), 66\u201378. https:\/\/doi.org\/10.1016\/j.trecan.2018.10.010","journal-title":"Trends Cancer"},{"issue":"11","key":"10390_CR92","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/ncb2861","volume":"15","author":"P Bragado","year":"2013","unstructured":"Bragado, P., Estrada, Y., Parikh, F., et al. (2013). TGF-\u03b22 dictates disseminated tumour cell fate in target organs through TGF-\u03b2-RIII and p38\u03b1\/\u03b2 signalling. Nature Cell Biology, 15(11), 1351\u20131361. https:\/\/doi.org\/10.1038\/ncb2861","journal-title":"Nature Cell Biology"},{"key":"10390_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120217","volume":"256","author":"Y Qiu","year":"2020","unstructured":"Qiu, Y., Qiu, S., Deng, L., et al. (2020). Biomaterial 3D collagen I gel culture model: A novel approach to investigate tumorigenesis and dormancy of bladder cancer cells induced by tumor microenvironment. Biomaterials, 256, Article 120217. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120217","journal-title":"Biomaterials"},{"issue":"1","key":"10390_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46320-w","volume":"15","author":"K Ohara","year":"2024","unstructured":"Ohara, K., Rendeiro, A. F., Bhinder, B., et al. (2024). The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis. Nature Communications, 15(1), Article 2009. https:\/\/doi.org\/10.1038\/s41467-024-46320-w","journal-title":"Nature Communications"},{"issue":"4","key":"10390_CR95","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.eururo.2022.01.026","volume":"81","author":"JA Nakauma-Gonz\u00e1lez","year":"2022","unstructured":"Nakauma-Gonz\u00e1lez, J. A., Rijnders, M., van Riet, J., et al. (2022). Comprehensive molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma. European Urology, 81(4), 331\u2013336. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.026","journal-title":"European Urology"},{"issue":"3","key":"10390_CR96","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.euo.2026.03.005","volume":"9","author":"I Duquesne","year":"2026","unstructured":"Duquesne, I., Epelbaum, I., Prost, D., et al. (2026). Blood and urine circulating tumor DNA in urothelial bladder cancer: State of the art and clinical perspective. European Urology Oncology, 9(3), 690\u2013704. https:\/\/doi.org\/10.1016\/j.euo.2026.03.005","journal-title":"European Urology Oncology"},{"issue":"4","key":"10390_CR97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000020010","volume":"36","author":"Y Fujii","year":"1999","unstructured":"Fujii, Y., Fukui, I., Kihara, K., et al. (1999). Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. European Urology, 36(4), 309\u2013313. https:\/\/doi.org\/10.1159\/000020010","journal-title":"European Urology"},{"key":"10390_CR98","doi-asserted-by":"publisher","first-page":"218444","DOI":"10.1016\/j.canlet.2026.218444","volume":"648","author":"J Liao","year":"2026","unstructured":"Liao, J., & Ji, Q. (2026). Fueling the fatal voyage: How metabolic plasticity empowers every step of cancer metastasis. Cancer Letters, 648, 218444. https:\/\/doi.org\/10.1016\/j.canlet.2026.218444","journal-title":"Cancer Letters"},{"issue":"7","key":"10390_CR99","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.chembiol.2026.02.014","volume":"33","author":"CE Hagan","year":"2026","unstructured":"Hagan, C. E., & Oberst, A. (2026). Too much of a good thing: Promotion of tumor progression and metastasis by apoptotic cells. Cell Chemical Biology, 33(7), 952\u2013965. https:\/\/doi.org\/10.1016\/j.chembiol.2026.02.014","journal-title":"Cell Chemical Biology"},{"key":"10390_CR100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2021.02.010","volume":"505","author":"S Liu","year":"2021","unstructured":"Liu, S., Chen, X., & Lin, T. (2021). Lymphatic metastasis of bladder cancer: Molecular mechanisms, diagnosis and targeted therapy. Cancer Letters, 505, 13\u201323. https:\/\/doi.org\/10.1016\/j.canlet.2021.02.010","journal-title":"Cancer Letters"},{"issue":"8","key":"10390_CR101","doi-asserted-by":"publisher","first-page":"e146431","DOI":"10.1172\/JCI146431","volume":"131","author":"C Chen","year":"2021","unstructured":"Chen, C., Zheng, H., Luo, Y., et al. (2021). SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. The Journal of Clinical Investigation, 131(8), e146431. https:\/\/doi.org\/10.1172\/JCI146431","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10390_CR102","doi-asserted-by":"publisher","first-page":"e12518","DOI":"10.1002\/jev2.12518","volume":"13","author":"Y Lin","year":"2024","unstructured":"Lin, Y., Zheng, H., Jia, L., et al. (2024). Integrin \u03b16-containing extracellular vesicles promote lymphatic remodelling for pre-metastatic niche formation in lymph nodes via interplay with CD151. Journal of Extracellular Vesicles (JEV), 13(10), e12518. https:\/\/doi.org\/10.1002\/jev2.12518","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"10390_CR103","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ccell.2026.01.003","volume":"44","author":"M Haist","year":"2026","unstructured":"Haist, M., Baertsch, M. A., Reticker-Flynn, N. E., et al. (2026). Lymph node colonization induces tissue remodeling via immunosuppressive fibroblast-myeloid cell niches supporting metastatic tolerance. Cancer Cell, 44(3), 604-623.e9. https:\/\/doi.org\/10.1016\/j.ccell.2026.01.003","journal-title":"Cancer Cell"},{"issue":"1","key":"10390_CR104","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12967-024-05864-7","volume":"23","author":"X Yang","year":"2025","unstructured":"Yang, X., Wu, X., Hao, X., et al. (2025). Unleashing the therapeutic potential of tumor-draining lymph nodes: Spotlight on bladder cancer. Journal of Translational Medicine, 23(1), 489. https:\/\/doi.org\/10.1186\/s12967-024-05864-7","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10390_CR105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12967-025-07534-8","volume":"24","author":"Z Wang","year":"2025","unstructured":"Wang, Z., Miao, J., Wang, M., et al. (2025). Single-cell and spatial atlas unveil tumor-specific microenvironment convergence and a prognosis-associated PLXDC1+ myofibroblast population in metastatic bladder cancer. Journal of Translational Medicine, 24(1), 88. https:\/\/doi.org\/10.1186\/s12967-025-07534-8","journal-title":"Journal of Translational Medicine"},{"issue":"3","key":"10390_CR106","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras, L., Shaashua, L., Matei, I., et al. (2023). Immune determinants of the pre-metastatic niche. Cancer Cell, 41(3), 546\u2013572. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.018","journal-title":"Cancer Cell"},{"issue":"4","key":"10390_CR107","doi-asserted-by":"publisher","first-page":"e011108","DOI":"10.1136\/jitc-2024-011108","volume":"13","author":"Y Tong","year":"2025","unstructured":"Tong, Y., Chen, Z., Wu, J., et al. (2025). METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5\/CCL5 regulation. Journal for Immunotherapy of Cancer, 13(4), e011108. https:\/\/doi.org\/10.1136\/jitc-2024-011108","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"1","key":"10390_CR108","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","volume":"24","author":"S He","year":"2025","unstructured":"He, S., Zheng, L., & Qi, C. (2025). Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy. Molecular Cancer, 24(1), 5. https:\/\/doi.org\/10.1186\/s12943-024-02208-3","journal-title":"Molecular Cancer"},{"issue":"8","key":"10390_CR109","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1172\/JCI89717","volume":"127","author":"MF Chevalier","year":"2017","unstructured":"Chevalier, M. F., Trabanelli, S., Racle, J., et al. (2017). ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence. The Journal of Clinical Investigation, 127(8), 2916\u20132929. https:\/\/doi.org\/10.1172\/JCI89717","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10390_CR110","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1038\/s41467-026-69841-y","volume":"17","author":"M Falquet","year":"2026","unstructured":"Falquet, M., El Ahanidi, H., Gomez-Cadena, A., et al. (2026). Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer. Nature Communications, 17(1), 3061. https:\/\/doi.org\/10.1038\/s41467-026-69841-y","journal-title":"Nature Communications"},{"issue":"6","key":"10390_CR111","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.eururo.2005.07.016","volume":"48","author":"M Retz","year":"2005","unstructured":"Retz, M., Sidhu, S. S., Lehmann, J., et al. (2005). New HIV-drug inhibits in vitro bladder cancer migration and invasion. European Urology, 48(6), 1025\u20131030. https:\/\/doi.org\/10.1016\/j.eururo.2005.07.016","journal-title":"European Urology"},{"issue":"6","key":"10390_CR112","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","volume":"22","author":"A Nazari","year":"2017","unstructured":"Nazari, A., Khorramdelazad, H., & Hassanshahi, G. (2017). Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer. International Journal of Clinical Oncology, 22(6), 991\u20131000. https:\/\/doi.org\/10.1007\/s10147-017-1187-x","journal-title":"International Journal of Clinical Oncology"},{"issue":"11","key":"10390_CR113","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang, Y., Li, J., Lei, W., et al. (2023). CXCL12-CXCR4\/CXCR7 axis in cancer: From mechanisms to clinical applications. International Journal of Biological Sciences, 19(11), 3341\u20133359. https:\/\/doi.org\/10.7150\/ijbs.82317","journal-title":"International Journal of Biological Sciences"},{"issue":"12","key":"10390_CR114","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/cells13121027","volume":"13","author":"Z Ma","year":"2024","unstructured":"Ma, Z., Zhou, F., Jin, H., et al. (2024). Crosstalk between CXCL12\/CXCR4\/ACKR3 and the STAT3 Pathway. Cells, 13(12), 1027. https:\/\/doi.org\/10.3390\/cells13121027","journal-title":"Cells"},{"issue":"4","key":"10390_CR115","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41590-026-02445-2","volume":"27","author":"S Ghosh","year":"2026","unstructured":"Ghosh, S., Li, X., Rawat, K., et al. (2026). Chemokine-defined macrophage niches establish spatial organization of tumor immunity. Nature Immunology, 27(4), 715\u2013724. https:\/\/doi.org\/10.1038\/s41590-026-02445-2","journal-title":"Nature Immunology"},{"issue":"4","key":"10390_CR116","doi-asserted-by":"publisher","first-page":"e71546","DOI":"10.1096\/fj.202504456RR","volume":"40","author":"H Chen","year":"2026","unstructured":"Chen, H., Peng, Y., Ji, Z., et al. (2026). SPP1+ macrophage-POSTN+ fibroblast-endothelial triad dictates immunotherapy response in bladder cancer. The FASEB Journal, 40(4), e71546. https:\/\/doi.org\/10.1096\/fj.202504456RR","journal-title":"The FASEB Journal"},{"issue":"17","key":"10390_CR117","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.7150\/thno.101575","volume":"14","author":"M Li","year":"2024","unstructured":"Li, M., Cui, Y., Qi, Q., et al. (2024). SPOP downregulation promotes bladder cancer progression based on cancer cell-macrophage crosstalk via STAT3\/CCL2\/IL-6 axis and is regulated by VEZF1. Theranostics, 14(17), 6543\u20136559. https:\/\/doi.org\/10.7150\/thno.101575","journal-title":"Theranostics"},{"key":"10390_CR118","doi-asserted-by":"publisher","first-page":"216964","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Y Yu","year":"2024","unstructured":"Yu, Y., Liang, Y., Xie, F., et al. (2024). Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Letters, 593, 216964. https:\/\/doi.org\/10.1016\/j.canlet.2024.216964","journal-title":"Cancer Letters"},{"key":"10390_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2026.102270","author":"Z Luo","year":"2026","unstructured":"Luo, Z., Xu, D., Wang, Z., et al. (2026). Charting the landscape of microbiota in bladder cancer: Molecular mechanisms and therapeutic implications. Genes & Diseases. https:\/\/doi.org\/10.1016\/j.gendis.2026.102270","journal-title":"Genes & Diseases"},{"issue":"1","key":"10390_CR120","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","volume":"44","author":"T Li","year":"2025","unstructured":"Li, T., Zhu, K., Tong, H., et al. (2025). Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. Journal of Experimental & Clinical Cancer Research, 44(1), 265. https:\/\/doi.org\/10.1186\/s13046-025-03487-4","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"24","key":"10390_CR121","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1158\/0008-5472.CAN-24-0940","volume":"84","author":"C Cui","year":"2024","unstructured":"Cui, C., Zhang, H., Yang, C., et al. (2024). Inhibition of JNK signaling overcomes cancer-associated fibroblast-mediated immunosuppression and enhances the efficacy of immunotherapy in bladder cancer. Cancer Research, 84(24), 4199\u20134213. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0940","journal-title":"Cancer Research"},{"issue":"31","key":"10390_CR122","doi-asserted-by":"publisher","first-page":"e2303230","DOI":"10.1002\/advs.202303230","volume":"10","author":"T Liang","year":"2023","unstructured":"Liang, T., Tao, T., Wu, K., et al. (2023). Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer. Advance Science (Weinheim, Baden-Wurttemberg, Germany), 10(31), e2303230. https:\/\/doi.org\/10.1002\/advs.202303230","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"10390_CR123","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","volume":"55","author":"D Yang","year":"2023","unstructured":"Yang, D., Liu, J., Qian, H., et al. (2023). Cancer-associated fibroblasts: From basic science to anticancer therapy. Experimental & Molecular Medicine, 55(7), 1322\u20131332. https:\/\/doi.org\/10.1038\/s12276-023-01013-0","journal-title":"Experimental & Molecular Medicine"},{"issue":"11","key":"10390_CR124","doi-asserted-by":"publisher","first-page":"e146987","DOI":"10.1172\/JCI146987","volume":"131","author":"S Bhattacharjee","year":"2021","unstructured":"Bhattacharjee, S., Hamberger, F., Ravichandra, A., et al. (2021). Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. The Journal of Clinical Investigation, 131(11), e146987. https:\/\/doi.org\/10.1172\/JCI146987","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10390_CR125","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ccell.2014.09.001","volume":"26","author":"K Shin","year":"2014","unstructured":"Shin, K., Lim, A., Zhao, C., et al. (2014). Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors. Cancer Cell, 26(4), 521\u2013533. https:\/\/doi.org\/10.1016\/j.ccell.2014.09.001","journal-title":"Cancer Cell"},{"issue":"4","key":"10390_CR126","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","volume":"6","author":"B Caramelo","year":"2023","unstructured":"Caramelo, B., Zagorac, S., Corral, S., et al. (2023). Cancer-associated fibroblasts in bladder cancer: Origin, biology, and therapeutic opportunities. European Urology Oncology, 6(4), 366\u2013375. https:\/\/doi.org\/10.1016\/j.euo.2023.02.011","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10390_CR127","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1158\/0008-5472.CAN-20-1144","volume":"81","author":"PR Dominguez-Gutierrez","year":"2021","unstructured":"Dominguez-Gutierrez, P. R., Kwenda, E. P., Donelan, W., et al. (2021). Hyal2 expression in tumor-associated myeloid cells mediates cancer-related inflammation in bladder cancer. Cancer Research, 81(3), 648\u2013657. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1144","journal-title":"Cancer Research"},{"key":"10390_CR128","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-026-01789-4","volume":"19","author":"J He","year":"2026","unstructured":"He, J., Zhou, Z., Cheng, G., et al. (2026). Neutrophil extracellular traps in the tumor microenvironment, metastasis, therapy, and beyond: Advances, challenges, and perspectives. Journal of Hematology & Oncology, 19, 29. https:\/\/doi.org\/10.1186\/s13045-026-01789-4","journal-title":"Journal of Hematology & Oncology"},{"issue":"8080","key":"10390_CR129","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41586-025-09278-3","volume":"645","author":"JM Adrover","year":"2025","unstructured":"Adrover, J. M., Han, X., Sun, L., et al. (2025). Neutrophils drive vascular occlusion, tumour necrosis and metastasis. Nature, 645(8080), 484\u2013495. https:\/\/doi.org\/10.1038\/s41586-025-09278-3","journal-title":"Nature"},{"issue":"2","key":"10390_CR130","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-025-00888-7","volume":"26","author":"MH Shahzad","year":"2026","unstructured":"Shahzad, M. H., Rayes, R. F., Cools-Lartigue, J., et al. (2026). Neutrophil extracellular traps in cancer. Nature Reviews Cancer, 26(2), 104\u2013117. https:\/\/doi.org\/10.1038\/s41568-025-00888-7","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10390_CR131","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s40164-024-00571-x","volume":"13","author":"SZ Xie","year":"2024","unstructured":"Xie, S. Z., Yang, L. Y., Wei, R., et al. (2024). Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis. Experimental Hematology & Oncology, 13(1), 111. https:\/\/doi.org\/10.1186\/s40164-024-00571-x","journal-title":"Experimental Hematology & Oncology"},{"issue":"11","key":"10390_CR132","doi-asserted-by":"publisher","first-page":"e012736","DOI":"10.1136\/jitc-2025-012736","volume":"13","author":"T Cai","year":"2025","unstructured":"Cai, T., Feng, T., Zhang, W., et al. (2025). Neutrophil extracellular traps-STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancer. Journal for Immunotherapy of Cancer, 13(11), e012736. https:\/\/doi.org\/10.1136\/jitc-2025-012736","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"1","key":"10390_CR133","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41467-021-23086-z","volume":"12","author":"S Shinde-Jadhav","year":"2021","unstructured":"Shinde-Jadhav, S., Mansure, J. J., Rayes, R. F., et al. (2021). Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer. Nature Communications, 12(1), 2776. https:\/\/doi.org\/10.1038\/s41467-021-23086-z","journal-title":"Nature Communications"},{"issue":"2","key":"10390_CR134","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/mc.23844","volume":"64","author":"B Shang","year":"2025","unstructured":"Shang, B., Hu, Z., Xie, R., et al. (2025). Predictive value of neutrophil extracellular traps in neoadjuvant chemotherapy for muscle-invasive bladder cancer. Molecular Carcinogenesis, 64(2), 305\u2013316. https:\/\/doi.org\/10.1002\/mc.23844","journal-title":"Molecular Carcinogenesis"},{"issue":"6409","key":"10390_CR135","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues, J., Shields, M. A., Ng, D., et al. (2018). Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science, 361(6409), Article eaao4227. https:\/\/doi.org\/10.1126\/science.aao4227","journal-title":"Science"},{"issue":"12","key":"10390_CR136","doi-asserted-by":"publisher","first-page":"e0145115","DOI":"10.1371\/journal.pone.0145115","volume":"10","author":"E Kurtagic","year":"2015","unstructured":"Kurtagic, E., Rich, C. B., Buczek-Thomas, J. A., et al. (2015). Neutrophil elastase-generated fragment of vascular endothelial growth factor-A stimulates macrophage and endothelial progenitor cell migration. PLoS One, 10(12), e0145115. https:\/\/doi.org\/10.1371\/journal.pone.0145115","journal-title":"PLoS One"},{"issue":"5","key":"10390_CR137","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","volume":"52","author":"\u00c1 Teijeira","year":"2020","unstructured":"Teijeira, \u00c1., Garasa, S., Gato, M., et al. (2020). CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity, 52(5), 856-871.e8. https:\/\/doi.org\/10.1016\/j.immuni.2020.03.001","journal-title":"Immunity"},{"issue":"1","key":"10390_CR138","doi-asserted-by":"publisher","first-page":"e190557","DOI":"10.1172\/JCI190557","volume":"136","author":"H Li","year":"2026","unstructured":"Li, H., Zhang, Y., Lin, J., et al. (2026). Tumor-derived neutrophil extracellular trap-associated DNA impairs treatment efficacy in breast cancer via CCDC25-dependent epithelial-mesenchymal transition. The Journal of Clinical Investigation, 136(1), e190557. https:\/\/doi.org\/10.1172\/JCI190557","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10390_CR139","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-025-00670-3","volume":"14","author":"F Gao","year":"2025","unstructured":"Gao, F., Peng, H., Gou, R., et al. (2025). Exploring neutrophil extracellular traps: Mechanisms of immune regulation and future therapeutic potential. Experimental Hematology & Oncology, 14(1), 80. https:\/\/doi.org\/10.1186\/s40164-025-00670-3","journal-title":"Experimental Hematology & Oncology"},{"issue":"1","key":"10390_CR140","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41419-025-08218-3","volume":"16","author":"M Brambilla","year":"2025","unstructured":"Brambilla, M., Zanichelli, A., Cancila, V., et al. (2025). Neutrophil extracellular traps in cancer: Immune modulation, therapy resistance, and the dilemma of targeting. Cell Death & Disease, 16(1), 882. https:\/\/doi.org\/10.1038\/s41419-025-08218-3","journal-title":"Cell Death & Disease"},{"key":"10390_CR141","doi-asserted-by":"publisher","first-page":"735590","DOI":"10.3389\/fmed.2021.735590","volume":"8","author":"C Mao","year":"2021","unstructured":"Mao, C., Xu, X., Ding, Y., et al. (2021). Optimization of BCG therapy targeting neutrophil extracellular traps, autophagy, and miRNAs in bladder cancer: Implications for personalized medicine. Frontiers in Medicine (Lausanne), 8, 735590. https:\/\/doi.org\/10.3389\/fmed.2021.735590","journal-title":"Front Med (Lausanne)"},{"issue":"21","key":"10390_CR142","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.3390\/ijms242115805","volume":"24","author":"MM Islam","year":"2023","unstructured":"Islam, M. M., & Takeyama, N. (2023). Role of neutrophil extracellular traps in health and disease pathophysiology: Recent insights and advances. International Journal of Molecular Sciences, 24(21), 15805. https:\/\/doi.org\/10.3390\/ijms242115805","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10390_CR143","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41556-024-01409-8","volume":"26","author":"AW Lambert","year":"2024","unstructured":"Lambert, A. W., Zhang, Y., & Weinberg, R. A. (2024). Cell-intrinsic and microenvironmental determinants of metastatic colonization. Nature Cell Biology, 26(5), 687\u2013697. https:\/\/doi.org\/10.1038\/s41556-024-01409-8","journal-title":"Nature Cell Biology"},{"issue":"8","key":"10390_CR144","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.ccell.2025.07.008","volume":"43","author":"CS Dai","year":"2025","unstructured":"Dai, C. S., Mishra, A., Edd, J., et al. (2025). Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications. Cancer Cell, 43(8), 1399\u20131422. https:\/\/doi.org\/10.1016\/j.ccell.2025.07.008","journal-title":"Cancer Cell"},{"issue":"9","key":"10390_CR145","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino, M., Rathmell, J. C., Galluzzi, L., et al. (2024). Cancer cell metabolism and antitumour immunity. Nature Reviews Immunology, 24(9), 654\u2013669. https:\/\/doi.org\/10.1038\/s41577-024-01026-4","journal-title":"Nature Reviews Immunology"},{"issue":"5","key":"10390_CR146","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.it.2025.11.002","volume":"47","author":"CY Wu","year":"2026","unstructured":"Wu, C. Y., Huang, C. X., Wei, Y., et al. (2026). Glycolytic diversity drives immune complexity in cancer. Trends in Immunology, 47(5), 436\u2013448. https:\/\/doi.org\/10.1016\/j.it.2025.11.002","journal-title":"Trends in Immunology"},{"issue":"1","key":"10390_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen, J., Huang, Z., Chen, Y., et al. (2025). Lactate and lactylation in cancer. Signal Transduction and Targeted Therapy, 10(1), Article 38. https:\/\/doi.org\/10.1038\/s41392-024-02082-x","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"10390_CR148","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ncb3094","volume":"17","author":"MY Fong","year":"2015","unstructured":"Fong, M. Y., Zhou, W., Liu, L., et al. (2015). Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nature Cell Biology, 17(2), 183\u2013194. https:\/\/doi.org\/10.1038\/ncb3094","journal-title":"Nature Cell Biology"},{"issue":"10","key":"10390_CR149","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey, S. M., Zhang, F., Ding, C., et al. (2021). Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metabolism, 33(10), 2040-2058.e10. https:\/\/doi.org\/10.1016\/j.cmet.2021.09.002","journal-title":"Cell Metabolism"},{"key":"10390_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1258442","volume":"13","author":"T Matsui","year":"2023","unstructured":"Matsui, T., Toda, Y., Sato, H., et al. (2023). Targeting acidic pre-metastatic niche in lungs by pH low insertion peptide and its utility for anti-metastatic therapy. Frontiers in Oncology, 13, Article 1258442. https:\/\/doi.org\/10.3389\/fonc.2023.1258442","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10390_CR151","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","volume":"15","author":"M Li","year":"2024","unstructured":"Li, M., Yu, J., Ju, L., et al. (2024). USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death & Disease, 15(1), 44. https:\/\/doi.org\/10.1038\/s41419-024-06446-7","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10390_CR152","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12967-023-04805-0","volume":"22","author":"M Tan","year":"2024","unstructured":"Tan, M., Pan, Q., Yu, C., et al. (2024). PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by modulating GLUT1 glycosylation and membrane trafficking. Journal of Translational Medicine, 22(1), 5. https:\/\/doi.org\/10.1186\/s12967-023-04805-0","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10390_CR153","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13046-025-03591-5","volume":"44","author":"T Wang","year":"2025","unstructured":"Wang, T., Ma, X., Wang, Y., et al. (2025). Lactate-driven lactylation of HNRNPA1 orchestrates PKM2 splicing and glycolytic reprogramming in bladder cancer. Journal of Experimental & Clinical Cancer Research, 44(1), 331. https:\/\/doi.org\/10.1186\/s13046-025-03591-5","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"14","key":"10390_CR154","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.7150\/thno.71456","volume":"12","author":"P Liu","year":"2022","unstructured":"Liu, P., Fan, B., Othmane, B., et al. (2022). m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism. Theranostics, 12(14), 6291\u20136307. https:\/\/doi.org\/10.7150\/thno.71456","journal-title":"Theranostics"},{"issue":"1","key":"10390_CR155","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-025-04554-5","volume":"24","author":"YT Chen","year":"2025","unstructured":"Chen, Y. T., Sui, J., Yang, Y., et al. (2025). Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects of pentadecanoic acid on bladder cancer. BMC Medicine, 24(1), 10. https:\/\/doi.org\/10.1186\/s12916-025-04554-5","journal-title":"BMC Medicine"},{"issue":"20","key":"10390_CR156","doi-asserted-by":"publisher","first-page":"e2408311","DOI":"10.1002\/advs.202408311","volume":"12","author":"K Xiong","year":"2025","unstructured":"Xiong, K., Chen, S., Xu, H., et al. (2025). RNF112 facilitates ubiquitin-mediated degradation of c-Myc, suppressing proliferation, migration and lipid synthesis in bladder cancer. Advance Science (Weinheim, Baden-Wurttemberg, Germany), 12(20), e2408311. https:\/\/doi.org\/10.1002\/advs.202408311","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10390_CR157","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41419-022-04506-4","volume":"13","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Wang, X. Y., Zhang, P., et al. (2022). Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts. Cell Death & Disease, 13(1), 57. https:\/\/doi.org\/10.1038\/s41419-022-04506-4","journal-title":"Cell Death & Disease"},{"issue":"2","key":"10390_CR158","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s12276-026-01650-1","volume":"58","author":"TH Kim","year":"2026","unstructured":"Kim, T. H., Lim, S. H., Lee, H., et al. (2026). Metabolic crosstalk among cancer-associated fibroblasts, adipocytes and immune cells as an immunosuppressive tumor microenvironment driver. Experimental & Molecular Medicine, 58(2), 366\u2013381. https:\/\/doi.org\/10.1038\/s12276-026-01650-1","journal-title":"Experimental & Molecular Medicine"},{"key":"10390_CR159","doi-asserted-by":"publisher","first-page":"1593523","DOI":"10.3389\/fimmu.2025.1593523","volume":"16","author":"P Zhang","year":"2025","unstructured":"Zhang, P., Zhang, H., Yu, W., et al. (2025). A lactate-related tSNE signature defines prognostic subtypes of bladder cancer and reveals LINC01094-mediated VIM stabilization in metastasis and drug resistance. Frontiers in Immunology, 16, 1593523. https:\/\/doi.org\/10.3389\/fimmu.2025.1593523","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10390_CR160","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12944-021-01554-1","volume":"20","author":"K Zhu","year":"2021","unstructured":"Zhu, K., Xiaoqiang, L., Deng, W., et al. (2021). Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Lipids in Health and Disease, 20(1), 146. https:\/\/doi.org\/10.1186\/s12944-021-01554-1","journal-title":"Lipids in Health and Disease"},{"key":"10390_CR161","doi-asserted-by":"publisher","first-page":"1111319","DOI":"10.3389\/fimmu.2023.1111319","volume":"14","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Xia, Z., Sun, X., et al. (2023). Identification of a glutamine metabolism reprogramming signature for predicting prognosis, immunotherapy efficacy, and drug candidates in bladder cancer. Frontiers in Immunology, 14, 1111319. https:\/\/doi.org\/10.3389\/fimmu.2023.1111319","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10390_CR162","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3390\/ijms25063347","volume":"25","author":"F Pereira","year":"2024","unstructured":"Pereira, F., Domingues, M. R., Vitorino, R., et al. (2024). Unmasking the metabolite signature of bladder cancer: A systematic review. International Journal of Molecular Sciences, 25(6), 3347. https:\/\/doi.org\/10.3390\/ijms25063347","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10390_CR163","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M., et al. (2022). Targeting cancer metabolism in the era of precision oncology. Nature Reviews. Drug Discovery, 21(2), 141\u2013162. https:\/\/doi.org\/10.1038\/s41573-021-00339-6","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10390_CR164","doi-asserted-by":"publisher","first-page":"217076","DOI":"10.1016\/j.canlet.2024.217076","volume":"597","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Zhao, Y., Song, H., et al. (2024). Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications. Cancer Letters, 597, 217076. https:\/\/doi.org\/10.1016\/j.canlet.2024.217076","journal-title":"Cancer Letters"},{"issue":"1","key":"10390_CR165","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41420-024-01807-9","volume":"10","author":"S Zhang","year":"2024","unstructured":"Zhang, S., Lv, K., Liu, Z., et al. (2024). Fatty acid metabolism of immune cells: A new target of tumour immunotherapy. Cell Death Discovery, 10(1), 39. https:\/\/doi.org\/10.1038\/s41420-024-01807-9","journal-title":"Cell Death Discov"},{"issue":"5","key":"10390_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051145","volume":"13","author":"F Liu","year":"2025","unstructured":"Liu, F., Li, K., & Zhu, Q. (2025). Targeting metabolic reprogramming in bladder cancer immunotherapy: A precision medicine approach. Biomedicines, 13(5), Article 1145. https:\/\/doi.org\/10.3390\/biomedicines13051145","journal-title":"Biomedicines"},{"issue":"16","key":"10390_CR167","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.7150\/thno.25130","volume":"8","author":"A Yeon","year":"2018","unstructured":"Yeon, A., You, S., Kim, M., et al. (2018). Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism. Theranostics, 8(16), 4520\u20134534. https:\/\/doi.org\/10.7150\/thno.25130","journal-title":"Theranostics"},{"issue":"2","key":"10390_CR168","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran, L., Xiao, J. F., Agarwal, N., et al. (2021). Advances in bladder cancer biology and therapy. Nature Reviews Cancer, 21(2), 104\u2013121. https:\/\/doi.org\/10.1038\/s41568-020-00313-1","journal-title":"Nature Reviews Cancer"},{"issue":"17","key":"10390_CR169","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.3390\/ijms25179696","volume":"25","author":"E Tonni","year":"2024","unstructured":"Tonni, E., Oltrecolli, M., Pirola, M., et al. (2024). New advances in metastatic urothelial cancer: A narrative review on recent developments and future perspectives. International Journal of Molecular Sciences, 25(17), 9696. https:\/\/doi.org\/10.3390\/ijms25179696","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10390_CR170","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.devcel.2019.04.012","volume":"49","author":"Y Gao","year":"2019","unstructured":"Gao, Y., Bado, I., Wang, H., et al. (2019). Metastasis organotropism: Redefining the congenial soil. Developmental Cell, 49(3), 375\u2013391. https:\/\/doi.org\/10.1016\/j.devcel.2019.04.012","journal-title":"Developmental Cell"},{"issue":"1","key":"10390_CR171","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi, X., Wang, X., Yao, W., et al. (2024). Mechanism insights and therapeutic intervention of tumor metastasis: Latest developments and perspectives. Signal Transduction and Targeted Therapy, 9(1), 192. https:\/\/doi.org\/10.1038\/s41392-024-01885-2","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10390_CR172","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ijc.34715","volume":"154","author":"G Sj\u00f6dahl","year":"2024","unstructured":"Sj\u00f6dahl, G., Eriksson, P., Holmsten, K., et al. (2024). Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer. International Journal of Cancer, 154(1), 180\u2013190. https:\/\/doi.org\/10.1002\/ijc.34715","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10390_CR173","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun, A., de Reyni\u00e8s, A., Allory, Y., et al. (2020). A consensus molecular classification of muscle-invasive bladder cancer. European Urology, 77(4), 420\u2013433. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006","journal-title":"European Urology"},{"issue":"4","key":"10390_CR174","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.eururo.2023.03.020","volume":"85","author":"A Cox","year":"2024","unstructured":"Cox, A., Kl\u00fcmper, N., Stein, J., et al. (2024). Molecular urothelial tumor cell subtypes remain stable during metastatic evolution. European Urology, 85(4), 328\u2013332. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.020","journal-title":"European Urology"},{"issue":"7578","key":"10390_CR175","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A., Costa-Silva, B., Shen, T. L., et al. (2015). Tumour exosome integrins determine organotropic metastasis. Nature, 527(7578), 329\u2013335. https:\/\/doi.org\/10.1038\/nature15756","journal-title":"Nature"},{"issue":"6","key":"10390_CR176","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B., Aiello, N. M., Ocean, A. J., et al. (2015). Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology, 17(6), 816\u2013826. https:\/\/doi.org\/10.1038\/ncb3169","journal-title":"Nature Cell Biology"},{"issue":"6","key":"10390_CR177","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H., Ale\u010dkovi\u0107, M., Lavotshkin, S., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine, 18(6), 883\u2013891. https:\/\/doi.org\/10.1038\/nm.2753","journal-title":"Nature Medicine"},{"issue":"1","key":"10390_CR178","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1172\/JCI130892","volume":"130","author":"C Chen","year":"2020","unstructured":"Chen, C., Luo, Y., He, W., et al. (2020). Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. The Journal of Clinical Investigation, 130(1), 404\u2013421. https:\/\/doi.org\/10.1172\/JCI130892","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10390_CR179","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/cr.2015.153","volume":"26","author":"Y Liu","year":"2016","unstructured":"Liu, Y., & Cao, X. (2016). Organotropic metastasis: Role of tumor exosomes. Cell Research, 26(2), 149\u2013150. https:\/\/doi.org\/10.1038\/cr.2015.153","journal-title":"Cell Research"},{"issue":"1","key":"10390_CR180","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/ijo.2017.4003","volume":"51","author":"Y Xiong","year":"2017","unstructured":"Xiong, Y., Huang, F., Li, X., et al. (2017). CCL21\/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK\/ERK1\/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer. International Journal of Oncology, 51(1), 75\u201390. https:\/\/doi.org\/10.3892\/ijo.2017.4003","journal-title":"International Journal of Oncology"},{"issue":"5","key":"10390_CR181","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41580-025-00922-4","volume":"27","author":"L Ripoll","year":"2026","unstructured":"Ripoll, L., Zickler, A. M., Vader, P., et al. (2026). Biology and therapeutic potential of extracellular vesicle targeting and uptake. Nature Reviews Molecular Cell Biology, 27(5), 358\u2013376. https:\/\/doi.org\/10.1038\/s41580-025-00922-4","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10390_CR182","doi-asserted-by":"publisher","first-page":"10052","DOI":"10.1016\/j.jbo.2024.100524","volume":"44","author":"MB Searcy","year":"2024","unstructured":"Searcy, M. B., & Johnson, R. W. (2024). Epigenetic control of the vicious cycle. Journal of Bone Oncology (JBO), 44, 10052. https:\/\/doi.org\/10.1016\/j.jbo.2024.100524","journal-title":"J Bone Oncol."},{"issue":"9","key":"10390_CR183","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","volume":"184","author":"W Zhang","year":"2021","unstructured":"Zhang, W., Bado, I. L., Hu, J., et al. (2021). The bone microenvironment invigorates metastatic seeds for further dissemination. Cell, 184(9), 2471-2486.e20. https:\/\/doi.org\/10.1016\/j.cell.2021.03.011","journal-title":"Cell"},{"issue":"1","key":"10390_CR184","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","volume":"8","author":"M Wang","year":"2020","unstructured":"Wang, M., Xia, F., Wei, Y., et al. (2020). Molecular mechanisms and clinical management of cancer bone metastasis. Bone Research, 8(1), 30. https:\/\/doi.org\/10.1038\/s41413-020-00105-1","journal-title":"Bone Res"},{"key":"10390_CR185","doi-asserted-by":"publisher","first-page":"100597","DOI":"10.1016\/j.jbo.2024.100597","volume":"45","author":"J Zarrer","year":"2024","unstructured":"Zarrer, J., & Taipaleenm\u00e4ki, H. (2024). The osteoblast in regulation of tumor cell dormancy and bone metastasis. Journal of Bone Oncology (JBO), 45, 100597. https:\/\/doi.org\/10.1016\/j.jbo.2024.100597","journal-title":"J Bone Oncol"},{"issue":"5","key":"10390_CR186","doi-asserted-by":"publisher","first-page":"102179","DOI":"10.1016\/j.clgc.2024.102179","volume":"22","author":"A Drouaud","year":"2024","unstructured":"Drouaud, A., Xu, V., Velasquez, A., et al. (2024). Metastatic tropism in urothelial carcinoma with variant histology: A comprehensive NCDB analysis. Clinical Genitourinary Cancer, 22(5), 102179. https:\/\/doi.org\/10.1016\/j.clgc.2024.102179","journal-title":"Clinical Genitourinary Cancer"},{"issue":"2","key":"10390_CR187","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41585-025-01066-y","volume":"23","author":"K Wu","year":"2026","unstructured":"Wu, K., Liu, X., Zhang, J., et al. (2026). Mechanisms and implications of epithelial cell plasticity in the bladder. Nature Reviews Urology, 23(2), 70\u201388. https:\/\/doi.org\/10.1038\/s41585-025-01066-y","journal-title":"Nature Reviews Urology"},{"issue":"1","key":"10390_CR188","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s40164-025-00682-z","volume":"14","author":"C Bernardo","year":"2025","unstructured":"Bernardo, C., Chattopadhyay, S., Andersson, N., et al. (2025). Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases. Experimental Hematology & Oncology, 14(1), 91. https:\/\/doi.org\/10.1186\/s40164-025-00682-z","journal-title":"Experimental Hematology & Oncology"},{"issue":"1","key":"10390_CR189","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41467-025-57633-9","volume":"16","author":"Y Li","year":"2025","unstructured":"Li, Y., Fu, B., Wang, M., et al. (2025). Urinary extracellular vesicle N-glycomics identifies diagnostic glycosignatures for bladder cancer. Nature Communications, 16(1), 2292. https:\/\/doi.org\/10.1038\/s41467-025-57633-9","journal-title":"Nature Communications"},{"issue":"8","key":"10390_CR190","doi-asserted-by":"publisher","first-page":"102246","DOI":"10.1016\/j.xcrm.2025.102246","volume":"6","author":"IB Moreira","year":"2025","unstructured":"Moreira, I. B., Rossdam, C., Kaynert, J., et al. (2025). Neolactotetraosylceramide enables urinary detection of bladder cancer. Cell Reports Medicine, 6(8), 102246. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102246","journal-title":"Cell Rep Med"},{"issue":"4","key":"10390_CR191","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.7150\/thno.107213","volume":"15","author":"N Sun","year":"2025","unstructured":"Sun, N., Zhang, Z., Yang, X., et al. (2025). Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer. Theranostics, 15(4), 1272\u20131284. https:\/\/doi.org\/10.7150\/thno.107213","journal-title":"Theranostics"},{"issue":"2","key":"10390_CR192","doi-asserted-by":"publisher","first-page":"e12402","DOI":"10.1002\/jev2.12402","volume":"13","author":"L Dong","year":"2024","unstructured":"Dong, L., Feng, M., Kuczler, M. D., et al. (2024). Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer. Journal of Extracellular Vesicles (JEV), 13(2), e12402. https:\/\/doi.org\/10.1002\/jev2.12402","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10390_CR193","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41571-024-00967-y","volume":"22","author":"K Pantel","year":"2025","unstructured":"Pantel, K., & Alix-Panabi\u00e8res, C. (2025). Minimal residual disease as a target for liquid biopsy in patients with solid tumours. Nature Reviews Clinical Oncology, 22(1), 65\u201377. https:\/\/doi.org\/10.1038\/s41571-024-00967-y","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"4","key":"10390_CR194","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan, J. C. M., Massie, C., Garcia-Corbacho, J., et al. (2017). Liquid biopsies come of age: Towards implementation of circulating tumour DNA. Nature Reviews Cancer, 17(4), 223\u2013238. https:\/\/doi.org\/10.1038\/nrc.2017.7","journal-title":"Nature Reviews Cancer"},{"issue":"18","key":"10390_CR195","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.18.02052","volume":"37","author":"E Christensen","year":"2019","unstructured":"Christensen, E., Birkenkamp-Demtr\u00f6der, K., Sethi, H., et al. (2019). Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma. Journal of Clinical Oncology, 37(18), 1547\u20131557. https:\/\/doi.org\/10.1200\/JCO.18.02052","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10390_CR196","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/BLC-230105","volume":"10","author":"TF Stewart","year":"2024","unstructured":"Stewart, T. F., Chalfin, H., Simon, N., et al. (2024). Perioperative use of ctDNA to guide treatment for urothelial carcinoma: The future is now. Bladder Cancer, 10(3), 183\u2013198. https:\/\/doi.org\/10.3233\/BLC-230105","journal-title":"Bladder Cancer"},{"issue":"5","key":"10390_CR197","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.annonc.2025.12.018","volume":"37","author":"L Dyrskj\u00f8t","year":"2026","unstructured":"Dyrskj\u00f8t, L., Birkenkamp-Demtr\u00f6der, K., Nordentoft, I., et al. (2026). CtDNA-guided immunotherapy following radical cystectomy for muscle-invasive bladder cancer: Results from the TOMBOLA trial. Annals of Oncology, 37(5), 712\u2013724. https:\/\/doi.org\/10.1016\/j.annonc.2025.12.018","journal-title":"Annals of Oncology"},{"issue":"7867","key":"10390_CR198","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41586-021-03642-9","volume":"595","author":"T Powles","year":"2021","unstructured":"Powles, T., Assaf, Z. J., Davarpanah, N., et al. (2021). CtDNA guiding adjuvant immunotherapy in urothelial carcinoma. Nature, 595(7867), 432\u2013437. https:\/\/doi.org\/10.1038\/s41586-021-03642-9","journal-title":"Nature"},{"issue":"2","key":"10390_CR199","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.eururo.2023.06.007","volume":"85","author":"T Powles","year":"2024","unstructured":"Powles, T., Assaf, Z. J., Degaonkar, V., et al. (2024). Updated overall survival by circulating tumor DNA status from the phase 3 IMvigor010 trial: Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma. European Urology, 85(2), 114\u2013122. https:\/\/doi.org\/10.1016\/j.eururo.2023.06.007","journal-title":"European Urology"},{"issue":"1","key":"10390_CR200","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.annonc.2025.09.139","volume":"37","author":"MD Galsky","year":"2026","unstructured":"Galsky, M. D., Gschwend, J. E., Milowsky, M. I., et al. (2026). Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274. Annals of Oncology, 37(1), 69\u201378. https:\/\/doi.org\/10.1016\/j.annonc.2025.09.139","journal-title":"Annals of Oncology"},{"issue":"24","key":"10390_CR201","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa2511885","volume":"393","author":"T Powles","year":"2025","unstructured":"Powles, T., Kann, A. G., Castellano, D., et al. (2025). ctDNA-guided adjuvant atezolizumab in muscle-invasive bladder cancer. New England Journal of Medicine, 393(24), 2395\u20132408. https:\/\/doi.org\/10.1056\/NEJMoa2511885","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10390_CR202","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/2159-8290.CD-18-0825","volume":"9","author":"JC Dudley","year":"2019","unstructured":"Dudley, J. C., Schroers-Martin, J., Lazzareschi, D. V., et al. (2019). Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discovery, 9(4), 500\u2013509. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0825","journal-title":"Cancer Discovery"},{"issue":"8","key":"10390_CR203","doi-asserted-by":"publisher","first-page":"e1003732","DOI":"10.1371\/journal.pmed.1003732","volume":"18","author":"PS Chauhan","year":"2021","unstructured":"Chauhan, P. S., Chen, K., Babbra, R. K., et al. (2021). Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study. PLoS Medicine, 18(8), e1003732. https:\/\/doi.org\/10.1371\/journal.pmed.1003732","journal-title":"PLoS Medicine"},{"issue":"7","key":"10390_CR204","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s41416-022-01860-0","volume":"127","author":"E Tomiyama","year":"2022","unstructured":"Tomiyama, E., Fujita, K., Matsuzaki, K., et al. (2022). EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer. British Journal of Cancer, 127(7), 1312\u20131323. https:\/\/doi.org\/10.1038\/s41416-022-01860-0","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10390_CR205","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12967-025-06138-6","volume":"23","author":"J Li","year":"2025","unstructured":"Li, J., Jiang, Y., Ma, M., et al. (2025). Epithelial cell diversity and immune remodeling in bladder cancer progression: Insights from single-cell transcriptomics. Journal of Translational Medicine, 23(1), 135. https:\/\/doi.org\/10.1186\/s12967-025-06138-6","journal-title":"Journal of Translational Medicine"},{"key":"10390_CR206","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li, F., Zhang, H., Huang, Y., et al. (2024). Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resistance Update, 73, 101059. https:\/\/doi.org\/10.1016\/j.drup.2024.101059","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10390_CR207","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","volume":"9","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Jia, J., Wang, F., et al. (2024). Pre-metastatic niche: Formation, characteristics and therapeutic implication. Signal Transduction and Targeted Therapy, 9(1), 236. https:\/\/doi.org\/10.1038\/s41392-024-01937-7","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10390_CR208","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jconrel.2020.06.037","volume":"325","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., Han, M., & Gao, J. (2020). Prognosis and targeting of pre-metastatic niche. Journal of Controlled Release, 325, 223\u2013234. https:\/\/doi.org\/10.1016\/j.jconrel.2020.06.037","journal-title":"Journal of Controlled Release"},{"issue":"1","key":"10390_CR209","doi-asserted-by":"publisher","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","volume":"9","author":"M Catalano","year":"2019","unstructured":"Catalano, M., & O\u2019Driscoll, L. (2019). Inhibiting extracellular vesicles formation and release: A review of EV inhibitors. Journal of Extracellular Vesicles (JEV), 9(1), 1703244. https:\/\/doi.org\/10.1080\/20013078.2019.1703244","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10390_CR210","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar, M. A., Baba, S. K., Sadida, H. Q., et al. (2024). Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduction and Targeted Therapy, 9(1), 27. https:\/\/doi.org\/10.1038\/s41392-024-01735-1","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10390_CR211","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1038\/s41598-020-62753-x","volume":"10","author":"S Hiltbrunner","year":"2020","unstructured":"Hiltbrunner, S., Mints, M., Eldh, M., et al. (2020). Urinary exosomes from bladder cancer patients show a residual cancer phenotype despite complete pathological downstaging. Science and Reports, 10(1), 5960. https:\/\/doi.org\/10.1038\/s41598-020-62753-x","journal-title":"Science and Reports"},{"issue":"1","key":"10390_CR212","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski, M., Carmo, N. B., Krumeich, S., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biology, 12(1), 19\u201330. https:\/\/doi.org\/10.1038\/ncb2000","journal-title":"Nature Cell Biology"},{"issue":"5867","key":"10390_CR213","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic, K., Hsu, C., Chiantia, S., et al. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science, 319(5867), 1244\u20131247. https:\/\/doi.org\/10.1126\/science.1153124","journal-title":"Science"},{"issue":"Pt 24","key":"10390_CR214","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1242\/jcs.128868","volume":"126","author":"M Colombo","year":"2013","unstructured":"Colombo, M., Moita, C., van Niel, G., et al. (2013). Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. Journal of Cell Science, 126(Pt 24), 5553\u20135565. https:\/\/doi.org\/10.1242\/jcs.128868","journal-title":"Journal of Cell Science"},{"issue":"2","key":"10390_CR215","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41556-019-0450-y","volume":"22","author":"AM Leidal","year":"2020","unstructured":"Leidal, A. M., Huang, H. H., Marsh, T., et al. (2020). The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nature Cell Biology, 22(2), 187\u2013199. https:\/\/doi.org\/10.1038\/s41556-019-0450-y","journal-title":"Nature Cell Biology"},{"issue":"19","key":"10390_CR216","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.3390\/cancers13194937","volume":"13","author":"J Linxweiler","year":"2021","unstructured":"Linxweiler, J., Kolbinger, A., Himbert, D., et al. (2021). Organ-specific uptake of extracellular vesicles secreted by urological cancer cells. Cancers (Basel)., 13(19), 4937. https:\/\/doi.org\/10.3390\/cancers13194937","journal-title":"Cancers (Basel)."},{"issue":"7798","key":"10390_CR217","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41586-020-2054-x","volume":"579","author":"Z Lu","year":"2020","unstructured":"Lu, Z., Zou, J., Li, S., et al. (2020). Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature, 579(7798), 284\u2013290. https:\/\/doi.org\/10.1038\/s41586-020-2054-x","journal-title":"Nature"},{"issue":"1","key":"10390_CR218","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","volume":"16","author":"M Li","year":"2023","unstructured":"Li, M., Yang, Y., Xiong, L., et al. (2023). Metabolism, metabolites, and macrophages in cancer. Journal of Hematology & Oncology, 16(1), 80. https:\/\/doi.org\/10.1186\/s13045-023-01478-6","journal-title":"Journal of Hematology & Oncology"},{"issue":"2","key":"10390_CR219","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","volume":"6","author":"R Jin","year":"2025","unstructured":"Jin, R., Neufeld, L., & McGaha, T. L. (2025). Linking macrophage metabolism to function in the tumor microenvironment. Nature Cancer, 6(2), 239\u2013252. https:\/\/doi.org\/10.1038\/s43018-025-00909-2","journal-title":"Nat Cancer"},{"issue":"10","key":"10390_CR220","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2312117","volume":"390","author":"T Powles","year":"2024","unstructured":"Powles, T., Valderrama, B. P., Gupta, S., et al. (2024). Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer. New England Journal of Medicine, 390(10), 875\u2013888. https:\/\/doi.org\/10.1056\/NEJMoa2312117","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10390_CR221","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","volume":"391","author":"T Powles","year":"2024","unstructured":"Powles, T., Catto, J. W. F., Galsky, M. D., et al. (2024). Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer. New England Journal of Medicine, 391(19), 1773\u20131786. https:\/\/doi.org\/10.1056\/NEJMoa2408154","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10390_CR222","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1056\/NEJMoa2401726","volume":"392","author":"AB Apolo","year":"2025","unstructured":"Apolo, A. B., Ballman, K. V., Sonpavde, G., et al. (2025). Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma. New England Journal of Medicine, 392(1), 45\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2401726","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10390_CR223","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-physiol-022724-104908","volume":"87","author":"MJ Davis","year":"2025","unstructured":"Davis, M. J., Zawieja, S. D., & King, P. D. (2025). Transport and immune functions of the lymphatic system. Annual Review of Physiology, 87(1), 151\u2013172. https:\/\/doi.org\/10.1146\/annurev-physiol-022724-104908","journal-title":"Annual Review of Physiology"},{"key":"10390_CR224","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev-immunol-041015-055354","volume":"35","author":"GJ Randolph","year":"2017","unstructured":"Randolph, G. J., Ivanov, S., Zinselmeyer, B. H., et al. (2017). The lymphatic system: Integral roles in immunity. Annual Review of Immunology, 35, 31\u201352. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055354","journal-title":"Annual Review of Immunology"},{"issue":"8","key":"10390_CR225","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri, R., & McAndrews, K. M. (2023). The role of extracellular vesicles in cancer. Cell, 186(8), 1610\u20131626. https:\/\/doi.org\/10.1016\/j.cell.2023.03.010","journal-title":"Cell"},{"issue":"1","key":"10390_CR226","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12967-026-07742-w","volume":"24","author":"M Silvestri","year":"2026","unstructured":"Silvestri, M., Fantini, C., Duranti, G., et al. (2026). Exercise-derived extracellular vesicles in oncology: A new frontier for translational nanomedicine. Journal of Translational Medicine, 24(1), 283. https:\/\/doi.org\/10.1186\/s12967-026-07742-w","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10390_CR227","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s11427-024-2852-9","volume":"69","author":"Y Gao","year":"2026","unstructured":"Gao, Y., Wei, D., Zhong, L., et al. (2026). Extracellular vesicles in cancer progression: Mechanisms and significance. Science China Life Sciences, 69(4), 1067\u20131075. https:\/\/doi.org\/10.1007\/s11427-024-2852-9","journal-title":"Sci China Life Sci"},{"issue":"16","key":"10390_CR228","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-11-3873","volume":"72","author":"J Sceneay","year":"2012","unstructured":"Sceneay, J., Chow, M. T., Chen, A., et al. (2012). Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Research, 72(16), 3906\u20133911. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3873","journal-title":"Cancer Research"},{"issue":"1","key":"10390_CR229","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12964-021-00768-1","volume":"19","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z., Zhang, Y., Zhang, Y., et al. (2021). Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression. Cell Communication and Signaling: CCS, 19(1), 93. https:\/\/doi.org\/10.1186\/s12964-021-00768-1","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10390_CR230","doi-asserted-by":"publisher","first-page":"1113756","DOI":"10.3389\/fimmu.2023.1113756","volume":"14","author":"Y Du","year":"2023","unstructured":"Du, Y., Liu, Y., Cao, J., et al. (2023). LDL receptor related protein 1 is an adverse prognostic biomarker that correlates with stromal remodeling and macrophages infiltration in bladder cancer. Frontiers in Immunology, 14, 1113756. https:\/\/doi.org\/10.3389\/fimmu.2023.1113756","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10390_CR231","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2023.07.014","volume":"85","author":"T Strandgaard","year":"2024","unstructured":"Strandgaard, T., Nordentoft, I., Birkenkamp-Demtr\u00f6der, K., et al. (2024). Field cancerization is associated with tumor development, T-cell exhaustion, and clinical outcomes in bladder cancer. European Urology, 85(1), 82\u201392. https:\/\/doi.org\/10.1016\/j.eururo.2023.07.014","journal-title":"European Urology"},{"issue":"5","key":"10390_CR232","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2026.03.023","volume":"44","author":"M Hu","year":"2026","unstructured":"Hu, M., Liu, D. A., Wortzel, I., et al. (2026). Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunity. Cancer Cell, 44(5), 965-982.e12. https:\/\/doi.org\/10.1016\/j.ccell.2026.03.023","journal-title":"Cancer Cell"},{"issue":"1","key":"10390_CR233","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40364-026-00918-y","volume":"14","author":"A Andrzejczak","year":"2026","unstructured":"Andrzejczak, A., Krajewski, W., Jasku\u0142a, E., et al. (2026). Soluble immune checkpoints as diagnostic biomarkers in bladder cancer. Biomarker Research, 14(1), 44. https:\/\/doi.org\/10.1186\/s40364-026-00918-y","journal-title":"Biomark Res"},{"issue":"5","key":"10390_CR234","doi-asserted-by":"publisher","first-page":"460","DOI":"10.20892\/j.issn.2095-3941.2024.0628","volume":"22","author":"T Zhong","year":"2025","unstructured":"Zhong, T., Sun, S., Zhao, M., et al. (2025). The mechanisms and clinical significance of CD8+ T cell exhaustion in anti-tumor immunity. Cancer Biology & Medicine, 22(5), 460\u2013480. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0628","journal-title":"Cancer Biology & Medicine"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10390-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10390-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10390-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:31:23Z","timestamp":1792639883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10390-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":234,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10390"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10390-7","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"79"}}